Table 3: Comparison of the changes in clinical parameters from
0-16 weeks between the two groups.
|
|
Basal insulin
group（n = 22） |
Premixed
insulin group （n = 21） |
P value |
|
Body weight （kg |
-0.68 ± 1.03 |
+0.38 ± 1.72 |
0.019 |
|
Body mass index
（kg/m2） |
-0.26 ± 0.39 |
+0.16 ± 0.69 |
0.016 |
|
HbA1c (%) |
-0.22 ± 0.88 |
-0.60 ± 0.78 |
0.143 |
|
Insulin dose
(U/day) |
-0.09 ± 2.88 |
-0.38 ± 2.48 |
0.726 |
|
Systolic clinic
blood pressure (mmHg) |
-6.47 ± 20.19 |
-5.45 ± 20.98 |
0.874 |
|
Diastolic
clinic blood pressure (mmHg) |
-5.67 ± 8.84 |
-5.40 ± 8.76 |
0.923 |
|
Total
cholesterol (mg/dL) |
-11.41 ±27.46 |
-13.90 ± 34.73 |
0.795 |
|
Triglyceride
(mg/dL) |
+8.45 ± 62.10 |
-6.67 ± 51.95 |
0.393 |
|
High-density
lipoprotein cholesterol (mg/dL) |
-4.36 ± 10.28 |
-2.76 ± 6.16 |
0.541 |
|
Low-density lipoprotein cholesterol (mg/dL) |
-8.74 ± 23.65 |
-9.81 ± 30.38 |
0.898 |
Values
are expressed as means ± S.D.